The use of patient registries for orphan drugs and rare diseases

被引：0
|
作者：
Clarke, Joe T. R. [1 ]
Hernberg-Stahl, Elizabeth [2 ]
机构：
[1] CHUS Hop Fleurimont, Serv Genet Med, Sherbrooke, PQ J1H 5N4, Canada
[2] Late Phase Solut Europe AB, Taby, Sweden
来源：
EJHP PRACTICE | 2010年 / 16卷 / 04期
关键词：
FABRY-DISEASE;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：30 / 31
页数：2
相关论文
共 50 条
  • [1] Rare diseases and orphan drugs
    Aronson, JK
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (03) : 243 - 245
  • [2] Rare diseases and orphan drugs
    Irena Melnikova
    Nature Reviews Drug Discovery, 2012, 11 : 267 - 268
  • [3] Rare diseases and orphan drugs
    Melnikova, Irena
    NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (04) : 267 - 268
  • [4] RARE DISEASES AND ORPHAN DRUGS
    DAINA, E
    LANCET, 1994, 343 (8912): : 1560 - 1561
  • [5] Orphan drugs and rare diseases
    Schulze-Bonhage, Andreas
    Stephani, Ulrich
    ZEITSCHRIFT FUR EPILEPTOLOGIE, 2019, 32 (04): : 263 - 263
  • [6] Rare diseases and orphan drugs
    Taruscio, Domenica
    Capozzoli, Fiorentino
    Frank, Claudio
    ANNALI DELL ISTITUTO SUPERIORE DI SANITA, 2011, 47 (01): : 83 - 93
  • [7] Rare diseases and "orphan" drugs
    Hillcoat, BL
    MEDICAL JOURNAL OF AUSTRALIA, 1998, 169 (02) : 69 - 70
  • [8] PATIENT REGISTRIES FOR RARE DISEASES
    Deliverska, Mariela
    JOURNAL OF IMAB, 2016, 22 (02): : 1166 - 1168
  • [9] Development of orphan drugs for rare diseases
    Yoo, Han-Wook
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2024, 67 (07) : 315 - 327
  • [10] Orphan drugs and rare diseases in Andorra
    Gea, E.
    Gil, E.
    Barral, N.
    Gonzalez, V.
    Soler, A.
    Avellanet, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 963 - 963
12345